Back to search
Invasive Streptococcal Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Streptococcal Infection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Streptococcal Infection trials you may qualify forAfter 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pn…
Infections are one of the key causes of newborn deaths. Among them, Group B Streptococcus (GBS) is the leading cause of sepsis and bacterial meningitis in the f…
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection
Streptococcus pyogenes, commonly referred to as Group A Streptococcus (GAS), has the ability to induce a diverse range of illnesses. In several European countr…
Phase 2 trial to evaluate safety and immunogenicity of Inventprise's (IVT) 25-valent pneumococcal conjugate vaccine (IVT PCV-25) in Healthy Infants
The goal of this registry is to collect and store important medical and non-health information on children from 0 to 18 years of age affected by early- (up to 2…